ÂÜÀòÂÒÂ×

Barbara Weber, MD, is the President and CEO of Tango Therapeutics, a biotechnology company focused on developing novel medicines for cancer patients, a role held since September 2017. In addition to leadership at Tango, Barbara serves as a Board Member for FogPharma and REVOLUTION Medicines, and holds the position of Venture Partner at Third Rock Ventures since 2015. Barbara's extensive experience includes previous roles as Senior Vice President of Oncology Translational Medicine at Novartis and Vice President of Oncology at GlaxoSmithKline. Academic contributions include serving as Professor of Medicine and Genetics at the University of Pennsylvania and Assistant Professor of Medicine at the University of Michigan. Barbara Weber earned a Doctor of Medicine degree from the University of Washington and a Bachelor's degree in Chemistry from the same institution.